The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Microbial and fungal protease inhibitors—current and potential applications
Open accessAbstract
Proteolytic enzymes play essential metabolic and regulatory functions in many biological processes and also offer a wide range of biotechnological applications. Because of their essential roles, their proteolytic activity needs to be tightly regulated. Therefore, small molecules and proteins that inhibit proteases can be versatile tools in the fields of medicine, agriculture and biotechnology. In medicine, protease inhibitors can be used as diagnostic or therapeutic agents for viral, bacterial, fungal and parasitic diseases as well as for treating cancer and immunological, neurodegenerative and cardiovascular diseases. They can be involved in crop protection against plant pathogens and herbivorous pests as well as against abiotic stress such as drought. Furthermore, protease inhibitors are indispensable in protein purification procedures to prevent undesired proteolysis during heterologous expression or protein extraction. They are also valuable tools for simple and effective purification of proteases, using affinity chromatography. Because there are such a large number and diversity of proteases in prokaryotes, yeasts, filamentous fungi and mushrooms, we can expect them to be a rich source of protease inhibitors as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis
Naglik, J. R., Challacombe, S. J., & Hube, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.400-428.2003 · Cited by 1,179
The urokinase plasminogen activator system: a target for anti-cancer therapy
Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312 · cited 2×
“for use in cancer treatment, including the urokinase plasminogen activator and matriptase (Abbenante and Fairlie 2005; Bialas and Kafarski 2009; Ulisse et al. 2009).”
MethodHuman gastrointestinal nematode infections: are new control methods required?
Stepek, G., Buttle, D. J., Duce, I. R., & Behnke, J. M. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00495.x · Cited by 140
The Design of Inhibitors for Medicinally Relevant Metalloproteins
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600204 · Cited by 132 · cited 1×
“Therefore, much has been invested in the search for an effective protease inhibitor for use in treatment (Jacobsen et al. 2007), but none has yet been developed, which would be used in clinic.”
BackgroundMajor Surface Protease of Trypanosomatids: One Size Fits All?
Yao, C. (2010) · Infection and Immunity · doi:10.1128/iai.00776-09 · Cited by 105
Cited by
Molecular Recognition in Chemical and Biological Systems
Persch, E., Dumele, O., & Diederich, F. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201408487 · Cited by 654
A biotechnology perspective of fungal proteases
Souza, P. M. D., Bittencourt, M. L. D. A., Caprara, C. C., Freitas, M. D., Almeida, R. P. C. D., Silveira, D., Fonseca, Y. M., Ferreira Filho, E. X., Pessoa Junior, A., & Magalhães, P. O. (2015) · Brazilian Journal of Microbiology · doi:10.1590/s1517-838246220140359 · Cited by 345
Boudreau, P. D., Miller, B. W., McCall, L.-I., Almaliti, J., Reher, R., Hirata, K., Le, T., Siqueira-Neto, J. L., Hook, V., & Gerwick, W. H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00294 · Cited by 57
Metadata
- Authors
- Sabotič, J., & Kos, J.
- Venue
- Applied Microbiology and Biotechnology
- Published
- 2012-01-05
- Volume
- 93
- Issue
- 4
- Pages
- 1351-1375
- ISSN
- 0175-7598 (ISSN-L)
- 1432-0614
- OpenAlex
- W2010173885
- Cited by
- 174
- References
- 5
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Microbial and fungal protease inhibitors—current and potential applications. https://app.cochat.ai/papers/10.1007/s00253-011-3834-x
- The paper
- Sabotič, J., & Kos, J. (2012). Microbial and fungal protease inhibitors—current and potential applications. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-011-3834-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.